WO2014174529A3 - Polymorphs of avanafil - Google Patents

Polymorphs of avanafil Download PDF

Info

Publication number
WO2014174529A3
WO2014174529A3 PCT/IN2014/000258 IN2014000258W WO2014174529A3 WO 2014174529 A3 WO2014174529 A3 WO 2014174529A3 IN 2014000258 W IN2014000258 W IN 2014000258W WO 2014174529 A3 WO2014174529 A3 WO 2014174529A3
Authority
WO
WIPO (PCT)
Prior art keywords
avanafil
polymorphs
preparation
provides
pharmaceutical compositions
Prior art date
Application number
PCT/IN2014/000258
Other languages
French (fr)
Other versions
WO2014174529A2 (en
Inventor
Bandi Parthasaradhi Reddy
Kura Rathnakar Reddy
Dasari Muralidhara Reddy
Sabbela SATYANARAYANA REDDY
Bandi Vamsi Krishna
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Publication of WO2014174529A2 publication Critical patent/WO2014174529A2/en
Publication of WO2014174529A3 publication Critical patent/WO2014174529A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Abstract

The present invention provides a novel polymorph of avanafil, process for its preparation and pharmaceutical compositions comprising it.
PCT/IN2014/000258 2013-04-23 2014-04-22 Polymorphs of avanafil WO2014174529A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1782/CHE/2013 2013-04-23
IN1782CH2013 2013-04-23

Publications (2)

Publication Number Publication Date
WO2014174529A2 WO2014174529A2 (en) 2014-10-30
WO2014174529A3 true WO2014174529A3 (en) 2015-04-02

Family

ID=51792467

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2014/000258 WO2014174529A2 (en) 2013-04-23 2014-04-22 Polymorphs of avanafil

Country Status (1)

Country Link
WO (1) WO2014174529A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106336401B (en) * 2015-07-15 2019-05-28 山东诚创医药技术开发有限公司 A kind of refining methd of avanaphil

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656935B2 (en) * 1999-09-16 2003-12-02 Tanabe Seiyaku Co., Ltd. Aromatic nitrogen-containing 6-membered cyclic compounds
US7625911B2 (en) * 2005-01-12 2009-12-01 Mai De Ltd. Amorphous form of erlotinib hydrochloride and its solid amorphous dispersion
WO2012051559A2 (en) * 2010-10-15 2012-04-19 Gilead Sciences, Inc. Compositions and methods of treating pulmonary hypertension

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656935B2 (en) * 1999-09-16 2003-12-02 Tanabe Seiyaku Co., Ltd. Aromatic nitrogen-containing 6-membered cyclic compounds
US6797709B2 (en) * 1999-09-16 2004-09-28 Tanabe Seiyaku Co., Ltd. Aromatic nitrogen-containing 6-membered cyclic compounds
US7625911B2 (en) * 2005-01-12 2009-12-01 Mai De Ltd. Amorphous form of erlotinib hydrochloride and its solid amorphous dispersion
WO2012051559A2 (en) * 2010-10-15 2012-04-19 Gilead Sciences, Inc. Compositions and methods of treating pulmonary hypertension

Also Published As

Publication number Publication date
WO2014174529A2 (en) 2014-10-30

Similar Documents

Publication Publication Date Title
EP3319606A4 (en) Pharmaceutical compound
EP3256454A4 (en) Integrated methods for chemical synthesis
EP3209653A4 (en) Process for the preparation of (r,s)-nicotine
EP3148959A4 (en) Integrated methods for chemical synthesis
EP3104860A4 (en) Pharmaceutical compounds
EP3188761A4 (en) Methods for formulating antibody drug conjugate compositions
WO2014125506A3 (en) A process for the preparation of ivacaftor and its intermediates
EP3158073B8 (en) Compositions and methods for making (s)-norcoclaurine and (s)-norlaudanosoline, and synthesis intermediates thereof
EP3233783A4 (en) Improved method for the synthesis of ferric oraganic compounds
EP3280408A4 (en) Process for the preparation of dicycloplatin
EP3349750A4 (en) Pharmaceutical compound
WO2015121877A3 (en) Polymorphs of lomitapide and its salts
EP3229791A4 (en) Novel polymorphs of ivacaftor, process for its preparation and pharmaceutical composition thereof
EP3272362A4 (en) Sustained-release pharmaceutical composition
WO2014207758A3 (en) Novel polymorph of regadenoson
EP3284743A4 (en) Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof
EP3207041A4 (en) An improved process for the preparation of lurasidone hydrochloride
EP3178834A4 (en) Chemical synthesis method for phillyrin
EP3068770A4 (en) Processes for the preparation of pyrimidinylcyclopentane compounds
EP3189033A4 (en) Pharmaceutical compounds
WO2014177978A3 (en) An improved process for the preparation of teriflunomide
EP3390369A4 (en) Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
EP3386944A4 (en) Process for preparation of lisdexamphetamine
EP3389643A4 (en) Novel muramyl peptide derivative compound, synthesis and uses thereof
EP3387005A4 (en) Novel muramyl peptide derivative compound, synthesis and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14787421

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 14787421

Country of ref document: EP

Kind code of ref document: A2